---
title: "Inspira Technologies Calls May 6 Meeting to Rebrand as QTREX Ltd."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282988362.md"
description: "Inspira Technologies Oxy B.. Ltd. has scheduled an Extraordinary General Meeting for May 6, 2026, to vote on a proposal to rebrand the company as QTREX Ltd. This change aims to align the company's identity with its new focus on quantum computing connectivity solutions. The board supports the rebranding, which will take effect upon approval from the Israeli Registrar of Companies. Currently, IINN stock has a Buy rating with a $2.00 price target, but analysts express concerns over the company's weak financial performance and bearish technical conditions."
datetime: "2026-04-16T11:08:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282988362.md)
  - [en](https://longbridge.com/en/news/282988362.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282988362.md)
---

# Inspira Technologies Calls May 6 Meeting to Rebrand as QTREX Ltd.

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

The latest announcement is out from Inspira Technologies Oxy BHN ( (IINN) ).

Inspira Technologies Oxy B.H.N. Ltd., an Israel-based medtech firm now pivoting toward quantum computing connectivity solutions, has convened an Extraordinary General Meeting of shareholders for May 6, 2026, in Ra’anana. Only holders of ordinary shares of record at the close of business on April 21, 2026, are entitled to notice of, and to vote at, the meeting.

At the meeting, shareholders will vote on a proposal to change the company’s name to “QTREX Ltd.”, or a similar approved name, and amend its articles of association accordingly. The board unanimously supports the rebranding, arguing it better aligns the company’s identity with its new quantum connectivity strategy, and the change will take effect once cleared by the Israeli Registrar of Companies.

The most recent analyst rating on (IINN) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.

**Spark’s Take on IINN Stock**

According to Spark, TipRanks’ AI Analyst, IINN is a Neutral.

The score is driven primarily by very weak financial performance (minimal/unstable revenue, sustained losses, and heavy cash burn) and bearish technical conditions (price below all key moving averages with negative MACD). Valuation provides limited support because the company is loss-making (negative P/E) and offers no dividend yield.

To see Spark’s full report on IINN stock, click here.

**More about Inspira Technologies Oxy BHN**

Inspira Technologies Oxy B.H.N. Ltd. is an Israel-based medical technology company that has recently shifted its strategic focus toward quantum computing connectivity solutions. The move reflects an effort to reposition its corporate identity and operations in a rapidly evolving deep-tech segment, potentially broadening its addressable market beyond traditional medtech.

**Average Trading Volume:** 655,166

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $22.14M

Find detailed analytics on IINN stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [IINN.US](https://longbridge.com/en/quote/IINN.US.md)
- [QTEX.US](https://longbridge.com/en/quote/QTEX.US.md)
- [IINNW.US](https://longbridge.com/en/quote/IINNW.US.md)

## Related News & Research

- [Inspira Completes Commercial Deployment of its AME System at a Tier-1 U.S. Defense Entity | IINN Stock News](https://longbridge.com/en/news/283009828.md)
- [Inspira Technologies Repositions as QTREX With Quantum Connectivity Push](https://longbridge.com/en/news/281767079.md)
- [Why quantum computing stock skyrocketed this week](https://longbridge.com/en/news/286690728.md)
- [POET Technologies Announces Closing of US$400 Million Investment | POET Stock News](https://longbridge.com/en/news/286785400.md)
- [NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones | NTHI Stock News](https://longbridge.com/en/news/286931037.md)